If a company builds assets at 16.4% a year, faster than its revenue growth rate of 3.2% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Jiangsu Hengrui Pharmaceuticals Co's average Total Assets Growth Rate was -6.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 7.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 16.40% per year.
During the past 10 years, the average Total Assets Growth Rate was 18.10% per year.
During the past 13 years, Jiangsu Hengrui Pharmaceuticals Co's highest 3-Year average Total Assets Growth Rate was 38.80%. The lowest was -10.60%. And the median was 21.60%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Jiangsu Hengrui Pharmaceuticals Co Total Assets Chart
Jiangsu Hengrui Pharmaceuticals Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Jiangsu Hengrui Pharmaceuticals Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Jiangsu Hengrui Pharmaceuticals Co Total Assets Related Terms
Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600276 has been successfully added to your 